ERNA Price / Book | Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc. (ERNA) Price / Book

2026-09-03: Price/Book Ratio 2.29.
2026-06-30: Price/Book Ratio 2.43.
2026-03-31: Price/Book Ratio 0.85.
2025-12-31: Price/Book Ratio 3.92.

Historical market capitalization divided by filed shareholder equity.

Available history: 2010-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	2.29
2026-06-30	2.43
2026-03-31	0.85
2025-12-31	3.92
2025-09-30	60.46
2025-06-30	77.46
2024-12-31	219.03
2023-12-31	1,635.36
2023-09-30	1,241.63
2023-06-30	1,185.97
2023-03-31	885.76
2022-12-31	511.34
2022-09-30	625.92
2022-06-30	15,166.4
2022-03-31	51,026.77
2021-12-31	3,189.67
2021-09-30	115,130.23
2021-06-30	112,658.8
2021-03-31	82,721.43
2020-09-30	7,710.48
2020-06-30	8,244.23
2020-03-31	7,364.15
2019-12-31	9,825.82
2019-09-30	22,995.74
2019-06-30	24.58
2019-03-31	26,001.36
2018-12-31	12,157.55
2018-09-30	27,799.59
2018-06-30	29,203.73
2018-03-31	49,488.45
2017-12-31	28,757.43
2017-09-30	38.13
2017-06-30	42.48
2017-03-31	54,982.16
2016-12-31	70,864.68
2016-09-30	109,765.05
2016-06-30	104,431.26
2016-03-31	3,428,746.29
2015-12-31	57,661.12
2015-09-30	4,929,928.87
2015-06-30	2,594,152.97
2015-03-31	3,380,185.27
2014-12-31	2,790,378.98
2014-09-30	1,811,623.84
2014-06-30	2,656,462.71
2014-03-31	4,494,374.34
2013-12-31	4,038,432.13
2013-09-30	2,601.55
2013-06-30	2,989.17
2013-03-31	1,858.18
2012-12-31	1,419,036.29
2012-09-30	1,539.15
2012-06-30	974.25
2012-03-31	1,720.36
2011-12-31	1,799.03
2011-09-30	2,386.05
2011-06-30	2,586.84
2010-12-31	1,830.04

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Pulmatrix, Inc. (PULM)	United States	$0.006B
ProPhase Labs, Inc. (PRPH)	United States	$0.006B	-0.06
Xenetic Biosciences, Inc. (XBIO)	United States	$0.006B
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63
Bolt Biotherapeutics, Inc. (BOLT)	United States	$0.007B	-0.26
SYNLOGIC, INC. (SYBX)	United States	$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)	United States	$0.007B	-0.97
Processa Pharmaceuticals, Inc. (PCSA)	United States	$0.005B
AMARIN CORP PLC\UK (AMRN)		$0.005B	-247.24
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B